Marco Bolis
Impact in
- Aging top 10%
- Cancer Research top 10%
Papers in
-
- Retinoids in leukemia and cellular processes 12
- Muscle Physiology and Disorders 3
-
- Prostate Cancer Treatment and Research 13
- Co-authors
- Enrico Garattini (26 shared papers)Maddalena Fratelli (22 shared papers)Mineko Terao (22 shared papers)Gabriela Paroni (15 shared papers)Adriana Zanetti (14 shared papers)Maurizio Gianni’ (12 shared papers)Mami Kurosaki (17 shared papers)Maria Monica Barzago (9 shared papers)
- Journals
- Nature Communications (7 papers)Oncotarget (4 papers)Cell Death and Disease (3 papers)Scientific Reports (3 papers)Cell Reports (3 papers)
- Partner nations
- ItalySwitzerlandUnited States
In The Last Decade
Marco Bolis
66 papers receiving 2k citations
Marco Bolis's Hit Papers
Peers
Comparison fields: 5 of 99
- Aging 31
- Cancer Research 180
- Oncology 267
- Molecular Biology 701
- Pharmacology 97
Countries citing papers authored by Marco Bolis
This map shows the geographic impact of Marco Bolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bolis more than expected).
Fields of papers citing papers by Marco Bolis
This network shows the impact of papers produced by Marco Bolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bolis. The network helps show where Marco Bolis may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Bolis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis Hit paper breakdown → | 2021 | 257 |
| 2 | 2023 | 134 | |
| 3 | 2021 | 124 | |
| 4 | 2014 | 119 | |
| 5 | 2022 | 95 | |
| 6 | 2016 | 93 | |
| 7 | 2024 | 74 | |
| 8 | 2021 | 68 | |
| 9 | 2015 | 64 | |
| 10 | 2018 | 64 | |
| 11 | 2012 | 53 | |
| 12 | 2020 | 49 | |
| 13 | 2023 | 49 | |
| 14 | 2015 | 48 | |
| 15 | Senescence in cancer Hit paper breakdown → | 2025 | 46 |
| 16 | 2019 | 45 | |
| 17 | 2021 | 37 | |
| 18 | 2016 | 34 | |
| 19 | 2020 | 34 | |
| 20 | 2015 | 33 |
About Marco Bolis
Marco Bolis is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Aging, having authored 66 papers that have together received 2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Retinoids in leukemia and cellular processes (12 papers), PARP inhibition in cancer therapy (4 papers), Telomeres, Telomerase, and Senescence (3 papers), Immune cells in cancer (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and Muscle Physiology and Disorders (3 papers). The work is most often cited by research in Aging (31 citations), Cancer Research (180 citations), Oncology (267 citations), Molecular Biology (701 citations) and Pharmacology (97 citations). Marco Bolis has collaborated with scholars based in Italy, Switzerland and United States. Frequent co-authors include Enrico Garattini, Maddalena Fratelli, Mineko Terao, Gabriela Paroni, Adriana Zanetti, Maurizio Gianni’, Mami Kurosaki, Maria Monica Barzago, Floriana Centritto and Silvio Ken Garattini. Their work appears in journals such as Nature Communications, Oncotarget, Cell Death and Disease, Scientific Reports and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.